Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 Feb 12;130(3):791–807. doi: 10.1007/s10549-011-1374-9

Fig. 1.

Fig. 1

Arrestin expression in breast cancer cell lines. Using Western blot analysis, arrestin2 and 3 expression was evaluated in five luminal and four basal-like breast cancer cell lines. E-cadherin and vimentin were used as markers of luminal and basal-like breast cancer, respectively. Expression of arrestin3 was similar between the subtypes. However, arrestin2 expression was subtype dependent, with expression greatest in luminal breast cancer cell lines